RECRUITINGOBSERVATIONAL
Triage Survey for Neurology Research Eligibility
About This Trial
TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.
Who May Be Eligible (Plain English)
Who May Qualify:
- Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
- Participant and study partner (when applicable) are at least 18 years old.
Who Should NOT Join This Trial:
- Participant lacks the language skills or cognitive ability to understand the screening process.
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
- Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
* Participant and study partner (when applicable) are at least 18 years old.
Exclusion Criteria:
* Participant lacks the language skills or cognitive ability to understand the screening process.
* Participant is pregnant, breast-feeding, or planning to become pregnant.
* History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
* Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
* Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
* Any condition that in the investigator's opinion makes a participant unsuitable for the study.
* Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.
Treatments Being Tested
OTHER
Survey
Participants will be surveyed on demographics, medical history, and current memory and cognitive concerns. Vitals signs, urine drug screen, blood draw may be collected.
OTHER
Optional Medication Washout
Participants taking memory medications which require a down-taper per the judgment of the study physicians may participate in a medication washout period during study screening.
Locations (3)
Copley Clinical
Boston, Massachusetts, United States
Adams Clinical
Watertown, Massachusetts, United States
Berman Clinical
New York, New York, United States